Loading...
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis
Bone atrophy and its related fragility fractures are frequent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their quality of life. In another study, we showed that parathyroid hormone 1-34 and anti-sclerostin antibody attenuates radiation-induced bone damage...
Na minha lista:
| Udgivet i: | FASEB J |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Federation of American Societies for Experimental Biology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731129/ https://ncbi.nlm.nih.gov/pubmed/28860152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201700375R |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|